BRAF and digestive system neoplasm: Within our data, we could not find a significant difference in tumor location in NRAS-mutated samples even if all specimens came from distal colon or rectum tumors; likewise, in BRAF mutational status there was no significant difference between the age of the patients and the presence of gene mutations (p-value = 0.06).